Podcast: This Week in Managed Care&amp;mdash;US Uninsured Rate Increases and Other Health News

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

These findings suggest the mental health burden in nonmelanoma skin cancer reflects broader social and clinical factors rather than disease-specific effects.

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

CLL-SLL image | Image Credit: © Saiful52-stock.adobe.com

January 28th 2026

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

This new study reveals venetoclax and rituximab effectively treat chronic lymphocytic leukemia, showing high response rates and prolonged progression-free survival.

January 20th 2026

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

The AAP’s 2026 immunization schedule preserves broader vaccine protections as the CDC narrows its federal recommendations. | Image credit: @Katherine Welles - stock.adobe.com .jpeg

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

AAP’s 2026 immunization schedule continues protection against 18 diseases as the CDC reduces its recommendations to 11.

Child receiving vaccine | Image credit: Drazen - stock.adobe.com

Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors

Experts raise concerns that CDC childhood immunization changes could reduce vaccine uptake and weaken trust in public health guidance.

Related Content

January 31st 2026

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

These findings suggest the mental health burden in nonmelanoma skin cancer reflects broader social and clinical factors rather than disease-specific effects.

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

January 28th 2026

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

This new study reveals venetoclax and rituximab effectively treat chronic lymphocytic leukemia, showing high response rates and prolonged progression-free survival.

January 20th 2026

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

AAP’s 2026 immunization schedule continues protection against 18 diseases as the CDC reduces its recommendations to 11.